PFE Stock Analysis: Buy, Sell, or Hold?
PFE - Pfizer Inc.
$26.44
0.34 (1.30%)
▲
BUY
MODERATE Confidence
Last Updated: January 30, 2026
Earnings: Feb 03, 2026
2d
Get Alerted When PFE Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
4 traders called PFE this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: PFE shows positive signals but monitor for confirmation. Market pricing in 1.5% growth. Moderate conviction.
💡 BUY OPPORTUNITY: PFE shows positive signals but monitor for confirmation. Market pricing in 1.5% growth. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$24.32
Based on -0.5% avg growth
INTRINSIC VALUE TODAY
$15.10
Trading above fair value
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 8.4x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: PFE is currently trading at $26.44, which is considered extended relative to its 30-day fair value range of $25.05 to $25.95. The stock's valuation (Forward PE: 8.8) is in line with its historical norms (8.4). At these levels, the market is pricing in 1.5% annual earnings growth.
Technical Outlook: Technically, PFE is in a uptrend. The price is approaching resistance at $26.83. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: PFE has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $28.78 (+10.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, PFE is in a uptrend. The price is approaching resistance at $26.83. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: PFE has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $28.78 (+10.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Fair Price Range
$25.05 -
$25.95
Company Quality Score
70/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
62.9%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($28.78)
- BULLISH: Expecting earnings turnaround to 1.5% growth with -5.9% revenue growth
Fair Price Analysis
30-Day Fair Range
$25.05 -
$25.95
Current vs Fair Value
EXTENDED
Support & Resistance Levels
Support Level
$25.09
Resistance Level
$26.83
Current Trend
Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
8.79
Wall Street Target
$28.78
(+10.3%)
Revenue Growth (YoY)
-5.9%
Earnings Growth (YoY)
-21.3%
Profit Margin
15.7%
Valuation Premium vs History
+1.5% premium
PE vs Historical
8.8 vs 8.4
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+1.5%
(market-implied from PE analysis)
1-Year Target
$26.49
(+2%)
2-Year Target
$26.89
(+3%)
3-Year Target
$27.29
(+5%)
3-Yr Target (if PE normalizes)
(PE: 9→8)
PE COMPRESSION
$26.08
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.3, Growth: -4.9%)
$56.86
(+118%)
Base:
(SPY PE: 8.8, Growth: -4.9%)
$22.42
(-14%)
Bear:
(PE: 7.5, Growth: -4.9%)
$19.06
(-27%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (15x PE), but valuation improves significantly next year (9x PE) as earnings recover.
Trailing PE: 15.03 | Current EPS (TTM): $1.72
Bull Case
$49.10
(+86%)
Analyst growth 72.6%, PE expands to 16.5
Base Case
$44.63
(+69%)
Market implied 72.6%, PE stable at 15.0
Bear Case
$17.58
(-34%)
Severe decline -20.0%, PE contracts to 12.8
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Last updated: January 30, 2026 7:45 PM ET
Data refreshes hourly during market hours. Next update: 8:45 PM
Data refreshes hourly during market hours. Next update: 8:45 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PFE showing a specific setup today?
Insider Activity (6 Months)
1
Buys
4
Sells
Net
INSIDERS SELLING
Recent Transactions
Ro Khanna
SELL
2025-09-15
Ro Khanna
SELL
2025-09-05
Gilbert Ray Cisneros, Jr.
SELL
2025-08-05
Featured in Portfolios
PFE is a key holding in these high-performance investment strategies.
Top Rated Drug Manufacturers - General Stocks
Top-rated stocks in Drug Manufacturers - General by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
LLY
Eli Lilly and Company |
STRONG BUY
29 analysts |
$1111 | 60 BUY |
|
GILD
Gilead Sciences Inc |
BUY
30 analysts |
$135 | 63 BUY |
|
AMGN
Amgen Inc |
HOLD
32 analysts |
$332 | 66 BUY |
|
ABBV
AbbVie Inc |
BUY
28 analysts |
$245 | 61 BUY |
|
BIIB
Biogen Inc |
HOLD
37 analysts |
$192 | 58 HOLD |
Advanced PFE Option Strategies
Professional options setups generated by AI based on today's PFE price and gamma walls.
